Edwin Spaans

592 total citations
16 papers, 437 citations indexed

About

Edwin Spaans is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, Edwin Spaans has authored 16 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Psychiatry and Mental health. Recurrent topics in Edwin Spaans's work include Epilepsy research and treatment (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Edwin Spaans is often cited by papers focused on Epilepsy research and treatment (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Edwin Spaans collaborates with scholars based in Netherlands, United States and Belgium. Edwin Spaans's co-authors include Dick Tibboel, Saskia N. de Wildt, Janneke N. Samsom, Miriam G. Mooij, P. A. M. Peeters, Ute I. Schwarz, Roger Gaedigk, Saskia Koene, Johannes B. van Goudoever and Jan Smeıtınk and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Clinical Pharmacokinetics and Archives of Disease in Childhood.

In The Last Decade

Edwin Spaans

16 papers receiving 429 citations

Peers

Edwin Spaans

PPCH

PHARM

ONCOL

PHARM

Joao N.S. Pereira Germany

Masako Asoh Japan

Takanobu Matsuzaki Japan

Jean Dinh United States

Georges Olive France

C von Bahr Sweden

Xiu-Lin Huang Japan

Bianca D. van Groen Netherlands

In‐Jin Jang South Korea

Dale K. Yu United States

Joao N.S. Pereira Germany

Edwin Spaans

169 ×1.0

PPCH

74 ×0.7

73 ×0.7

PHARM

257 ×2.6

ONCOL

62 ×0.8

PHARM

Citations per year, relative to Edwin Spaans Edwin Spaans (= 1×) peers Joao N.S. Pereira

Countries citing papers authored by Edwin Spaans

Since Specialization

Citations

This map shows the geographic impact of Edwin Spaans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin Spaans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin Spaans more than expected).

Fields of papers citing papers by Edwin Spaans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin Spaans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin Spaans. The network helps show where Edwin Spaans may publish in the future.

Co-authorship network of co-authors of Edwin Spaans

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin Spaans. A scholar is included among the top collaborators of Edwin Spaans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin Spaans. Edwin Spaans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Groen, Bianca D. van, Edwin Spaans, Adrianus C. J. M. de Bruijn, et al.. (2019). A Comprehensive Analysis of Ontogeny of Renal Drug Transporters: mRNA Analyses, Quantitative Proteomics, and Localization. Clinical Pharmacology & Therapeutics. 106(5). 1083–1092. 73 indexed citations

Janssen, Mariska M. H. P., Edwin Spaans, Imelda J. M. de Groot, et al.. (2019). Natural variability of daily physical activity measured by accelerometry in children with a mitochondrial disease. Mitochondrion. 47. 30–37. 6 indexed citations

Spaans, Edwin, Y. Simons‐Oosterhuis, Dick Tibboel, et al.. (2019). O30 A comprehensive analysis of ontogeny of renal drug transporters: mRNA analyses, quantitative proteomics and localization. Archives of Disease in Childhood. 104(6). e13.2–e13. 3 indexed citations

Flint, Robert B., Rob ter Heine, Edwin Spaans, et al.. (2018). Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns. European Journal of Clinical Pharmacology. 74(12). 1585–1591. 12 indexed citations

Janssen, Mirian C. H., Saskia Koene, Paul de Laat, et al.. (2018). The KHENERGY Study: Safety and Efficacy of KH176 in Mitochondrial m.3243A>G Spectrum Disorders. Clinical Pharmacology & Therapeutics. 105(1). 101–111. 46 indexed citations

Koene, Saskia, Edwin Spaans, Luc Van Bortel, et al.. (2017). KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteers. Orphanet Journal of Rare Diseases. 12(1). 163–163. 43 indexed citations

Mooij, Miriam G., Esther van Duijn, Catherijne A. J. Knibbe, et al.. (2014). Pediatric Microdose Study of [14C]Paracetamol to Study Drug Metabolism Using Accelerated Mass Spectrometry: Proof of Concept. Clinical Pharmacokinetics. 53(11). 1045–1051. 28 indexed citations

Mooij, Miriam G., Ute I. Schwarz, Barbara A. E. de Koning, et al.. (2014). Ontogeny of Human Hepatic and Intestinal Transporter Gene Expression during Childhood: Age Matters. Drug Metabolism and Disposition. 42(8). 1268–1274. 112 indexed citations

Dogterom, Peter, C. J. Timmer, Rik de Greef, et al.. (2012). Asenapine Safety, Tolerability, and Pharmacokinetics After Single and Multiple Doses in Healthy Volunteers. Clinical Pharmacology in Drug Development. 1(4). 131–143. 7 indexed citations

10.

Peeters, Pierre, Ingrid M. C. Kamerling, Chris Hogg, et al.. (2012). Early stage development of the glycine‐1 re‐uptake inhibitor SCH 900435: central nervous system effects compared with placebo in healthy men. British Journal of Clinical Pharmacology. 75(6). 1455–1467. 6 indexed citations

11.

Peeters, Pierre, Howard N. Bockbrader, Edwin Spaans, et al.. (2011). Asenapine Pharmacokinetics in Hepatic and Renal Impairment. Clinical Pharmacokinetics. 50(7). 471–481. 21 indexed citations

12.

Spaans, Edwin, et al.. (2010). Metabolism and Excretion of Asenapine in Healthy Male Subjects. Drug Metabolism and Disposition. 39(4). 580–590. 34 indexed citations

13.

Buntinx, Erik, et al.. (2010). P.2.d.011 Low dose pipamperone, enhancing antidepressant effect of citalopram, occupies 5HT2A 50–60% leaving D2 nearly drug free. European Neuropsychopharmacology. 20. S396–S397. 2 indexed citations

14.

Dogterom, Peter, et al.. (2008). P.3.d.008 Asenapine pharmacokinetics: influence of cytochrome p450 modulators and udp-glucuronyltransferase inhibition. European Neuropsychopharmacology. 18. S452–S453. 8 indexed citations

15.

Spaans, Edwin, et al.. (2003). Concomitant Use of Gepirone‐er and Lithium: An Interaction Study. Clinical Pharmacology & Therapeutics. 73(2). 2 indexed citations

16.

Spaans, Edwin, et al.. (2002). Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects. European Journal of Clinical Pharmacology. 58(6). 423–429. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact